CHRNA7 and atherosclerosis: The neurotransmitter receptor cholinergic alpha 7 nicotinic acetylcholine receptor subunit (α7nAChR) is expressed in human atherosclerotic plaques and experimental observations support that receptor activation by the neurotransmitter acetylcholine (ACh) attenuates atherosclerosis progression (34, 45).